Sign Up Today and Learn More About Avalyn Pharma Stock
Invest in or calculate the value of your shares in Avalyn Pharma or other pre-IPO companies through EquityZen's platform.
![Avalyn Pharma](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/avalynpharma_logo-a9f718ca7c0315ba.jpg)
Avalyn Pharma Stock
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
About Avalyn Pharma Stock
Founded
2011
Headquarters
Seattle, WA, US
Industries
Science and Engineering, Health Care, Biotechnology
Avalyn Pharma Press Mentions
Stay in the know about the latest news on Avalyn Pharma
Avalyn Pharma v. Vincent
globallegalchronicle • Aug 09, 2024
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief ...
finance • Jul 05, 2024
Douglas Carlson on LinkedIn: I'm incredibly excited to join such a strong team at Avalyn with a… | 24 comments
linkedin • Jul 05, 2024
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imaging Biomarker ...
globenewswire • Jun 05, 2024
Avalyn to Participate in Jefferies Global Healthcare Conference
globenewswire • Jun 05, 2024
Avalyn Pharma Management
Leadership team at Avalyn Pharma
Founder and CSO
Mark W. Surber
Board Member
Jill Carroll
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Avalyn Pharma current valuation
- Avalyn Pharma stock price
- Available deals in Avalyn Pharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Avalyn Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Avalyn Pharma through EquityZen funds. These investments are made available by existing Avalyn Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Avalyn Pharma stock?
Shareholders can sell their Avalyn Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."